Rep profile
Rep profile
Kathy Headley
company
Astra USA Inc.
Title
Professional Sales Representative
current home
Jacksonsville, FL
Territory: Southern Georgia and Jacksonville, Florida.
Customers: Cardiologists, allergists, pulmonologists, family practitioners, general practitioners, internal medicine and pediatricians.
Sales techniques "I have to believe in my products in order to sell them. I tell the physicians the pros and cons of a product. I also build relationships with the office staff, not just the physicians. I educate everyone in the office about my product. Finally, I listen to the needs of the office."
Motivation: "I like meeting different people and experiencing different personalities. I enjoy meeting with a variety of offices and traveling to see them. Success stories are wonderful to hear. It's nice to know that my products are working for physicians and patients."
Seeing "no sees:" "I am consistent but not aggressive. I try to think of creative ways to get the physician's attention. One physician hadn't seen a rep in 20 years. I sent back a piece of a heart model and attached a note that read, 'Don't break my heart.' The physician was so amused that he let me in to see him. I've called on him a couple of times since then."
Volunteer work: "I sponsor a 13-year-old girl through the Baptist Home for Children, an orphanage in Jacksonville, FL. I enjoy spending time with her and knowing that I am making a difference. I am also the activities chairperson for my church. Many of the office staffs I visit have become interested in volunteer work for a variety of organizations. Physicians are always letting me know about a charity or an organization looking for volunteers."
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.